Global Lapatinib Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Published On: October 2019 | Report ID: 207729 | Category: Pharmaceuticals and HealthcarePages: 104

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours.

Scope of the Report:

The global Lapatinib market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lapatinib.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Lapatinib market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lapatinib market by product type and applications/end industries.

Market Segment by Companies, this report covers

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

250 mg Tablets

Type II

Market Segment by Applications, can be divided into

Hospital

Drug store

Table of Contents

1 Lapatinib Market Overview

1.1 Product Overview and Scope of Lapatinib

1.2 Classification of Lapatinib by Types

1.2.1 Global Lapatinib Revenue Comparison by Types (2019-2024)

1.2.2 Global Lapatinib Revenue Market Share by Types in 2018

1.2.3 250 mg Tablets

1.2.4 Type II

1.3 Global Lapatinib Market by Application

1.3.1 Global Lapatinib Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospital

1.3.3 Drug store

1.4 Global Lapatinib Market by Regions

1.4.1 Global Lapatinib Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Lapatinib Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Lapatinib Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lapatinib Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Lapatinib Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lapatinib Status and Prospect (2014-2024)

1.5 Global Market Size of Lapatinib (2014-2024)

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Lapatinib Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Lapatinib Revenue, Gross Margin and Market Share (2017-2018)

3 Global Lapatinib Market Competition, by Players

3.1 Global Lapatinib Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Lapatinib Players Market Share

3.2.2 Top 10 Lapatinib Players Market Share

3.3 Market Competition Trend

4 Global Lapatinib Market Size by Regions

4.1 Global Lapatinib Revenue and Market Share by Regions

4.2 North America Lapatinib Revenue and Growth Rate (2014-2019)

4.3 Europe Lapatinib Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Lapatinib Revenue and Growth Rate (2014-2019)

4.5 South America Lapatinib Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Lapatinib Revenue and Growth Rate (2014-2019)

5 North America Lapatinib Revenue by Countries

5.1 North America Lapatinib Revenue by Countries (2014-2019)

5.2 USA Lapatinib Revenue and Growth Rate (2014-2019)

5.3 Canada Lapatinib Revenue and Growth Rate (2014-2019)

5.4 Mexico Lapatinib Revenue and Growth Rate (2014-2019)

6 Europe Lapatinib Revenue by Countries

6.1 Europe Lapatinib Revenue by Countries (2014-2019)

6.2 Germany Lapatinib Revenue and Growth Rate (2014-2019)

6.3 UK Lapatinib Revenue and Growth Rate (2014-2019)

6.4 France Lapatinib Revenue and Growth Rate (2014-2019)

6.5 Russia Lapatinib Revenue and Growth Rate (2014-2019)

6.6 Italy Lapatinib Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Lapatinib Revenue by Countries

7.1 Asia-Pacific Lapatinib Revenue by Countries (2014-2019)

7.2 China Lapatinib Revenue and Growth Rate (2014-2019)

7.3 Japan Lapatinib Revenue and Growth Rate (2014-2019)

7.4 Korea Lapatinib Revenue and Growth Rate (2014-2019)

7.5 India Lapatinib Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Lapatinib Revenue and Growth Rate (2014-2019)

8 South America Lapatinib Revenue by Countries

8.1 South America Lapatinib Revenue by Countries (2014-2019)

8.2 Brazil Lapatinib Revenue and Growth Rate (2014-2019)

8.3 Argentina Lapatinib Revenue and Growth Rate (2014-2019)

8.4 Colombia Lapatinib Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Lapatinib by Countries

9.1 Middle East and Africa Lapatinib Revenue by Countries (2014-2019)

9.2 Saudi Arabia Lapatinib Revenue and Growth Rate (2014-2019)

9.3 UAE Lapatinib Revenue and Growth Rate (2014-2019)

9.4 Egypt Lapatinib Revenue and Growth Rate (2014-2019)

9.5 Nigeria Lapatinib Revenue and Growth Rate (2014-2019)

9.6 South Africa Lapatinib Revenue and Growth Rate (2014-2019)

10 Global Lapatinib Market Segment by Type

10.1 Global Lapatinib Revenue and Market Share by Type (2014-2019)

10.2 Global Lapatinib Market Forecast by Type (2019-2024)

10.3 250 mg Tablets Revenue Growth Rate (2014-2024)

10.4 Type II Revenue Growth Rate (2014-2024)

11 Global Lapatinib Market Segment by Application

11.1 Global Lapatinib Revenue Market Share by Application (2014-2019)

11.2 Lapatinib Market Forecast by Application (2019-2024)

11.3 Hospital Revenue Growth (2014-2019)

11.4 Drug store Revenue Growth (2014-2019)

12 Global Lapatinib Market Size Forecast (2019-2024)

12.1 Global Lapatinib Market Size Forecast (2019-2024)

12.2 Global Lapatinib Market Forecast by Regions (2019-2024)

12.3 North America Lapatinib Revenue Market Forecast (2019-2024)

12.4 Europe Lapatinib Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Lapatinib Revenue Market Forecast (2019-2024)

12.6 South America Lapatinib Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Lapatinib Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.